HRT Financial’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
HRT Financial's PTPI Position: Q2 2025 in Review
HRT Financial sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 5,501 shares — an estimated $9K sold.
HRT Financial first reported a position in PTPI in Q1 2025 and held it in 1 quarter. The position peaked at $9K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.
- HRT Financial reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- HRT Financial sold 5,501 Petros Pharmaceuticals shares in Q2 2025, an estimated $9K.
- HRT Financial first reported a position in Petros Pharmaceuticals in Q1 2025 and held it in 1 quarter.
- HRT Financial's Petros Pharmaceuticals position peaked at $9K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.
Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.